Arboreal Bioinnovations Series A has officially closed at ₹230 crore (~$24M+), as publicly reported on 2026-07-30, making it one of the largest Series A fundraises in India’s specialty food ingredients sector. The round was co-led by EAAA Alternatives, the alternatives arm of Edelweiss, and agri-focused venture firm Omnivore. Existing investor Rainmatter by Zerodha also participated, reinforcing its continued support for the Lucknow-based deeptech company.
Quick Highlights
- Founders: Swati Pandey (Co-Founder & CEO) and Manish Chauhan (Co-Founder & COO)
- Lead Investors: EAAA Alternatives (Edelweiss) and Omnivore (co-led)
- Participating Investor: Rainmatter by Zerodha (existing backer)
- Investor Background: EAAA is the alternatives investment arm of Edelweiss; Omnivore is an agriculture-focused venture firm; Rainmatter is the venture platform of Zerodha
- Headquarters: Lucknow, Uttar Pradesh
- Announcement Date: 30 July 2026
Funding Breakdown
Use of Funds
As publicly reported, Arboreal Bioinnovations will deploy the fresh capital across three core areas: expanding its manufacturing capacity, strengthening research and development capabilities, and accelerating the commercialisation of its next generation of functional ingredients. The company’s integrated technology platform spans ingredient engineering, process R&D, formulation science, and precision manufacturing. Its current product portfolio covers next-generation proteins, cocoa-based ingredients, natural zero-calorie sweeteners, and functional fibres, with additional platforms stated to be under development.
Funding Timeline
This ₹230 crore Series A is the most recent and largest disclosed round for Arboreal Bioinnovations. The company had received prior backing from Rainmatter by Zerodha in earlier rounds before this Series A close, as publicly reported.
Expansion Plans
Co-Founder and CEO Swati Pandey has publicly stated the company’s intent to build science-led solutions “with innovation originating in India and reaching consumers globally,” signalling a global market ambition underpinned by the new capital. Co-Founder and COO Manish Chauhan has indicated the funds will enable deeper investment in science, manufacturing, and talent — pointing to both product and team scale-up ahead. The company’s contextual innovation model is designed to serve the specific nutritional, functional, sensory, and commercial requirements of Indian consumers and brands, while targeting broader international reach.
Significance
This round positions Arboreal Bioinnovations as a standout player in India’s nascent but rapidly growing specialty food ingredients space, having already supported over 300 product launches across more than 1,100 consumer brands and nutraceutical manufacturers over the past 18 months while doubling its growth year-on-year. The scale of the raise — among the largest Series A transactions recorded in this sector in India — signals deepening institutional conviction in deeptech-led ingredient innovation as a category. The participation of EAAA Alternatives and Omnivore alongside returning backer Rainmatter also reflects a multi-investor vote of confidence that bridges the intersection of food science, agri-tech, and consumer health. For the broader startup ecosystem, it underscores that B2B ingredient technology built out of Tier-2 cities like Lucknow can attract top-tier capital at significant scale.
These details have been verified against multiple publicly available reports as of 2026-07-30.
Stay updated with the latest startup funding news on The Courtroom.
Disclaimer: This report is compiled from publicly available sources and is for informational purposes only; funding figures are as publicly reported and may be subject to change.
